A synergistic team of expert scientists and experienced solution providers for customers, both locally and global, GenPAx is developing game-changing resources for the use of bacterial genome sequences for diagnostic genomics. Enabling more effective infection control strategies, and taking a lead in the fight against new and emergent pathogens and strains, antimicrobial resistance, and health-care and food-associated infections.
Analysis and customer service
Our driving force
We are building a bacterial genomics company based on precision, efficiency and collaboration – the bedrocks of our company – and the driving forces behind all decisions; whether it’s how to analyse genomic sequences or the best way to serve our customers.
Our success and your satisfaction
We work in a highly competitive field, so we’re investing in technology and research to make sure we meet our promises and stay ahead of the curve. Our commitment to precision, efficiency and collaboration guarantees our success and your satisfaction.
Misuse & overuse of antimicrobials are the main drivers in the development of drug-resistant pathogens
On average, someone in the US gets an antibiotic resistant infection every 11 secs and every 15 mins someone dies
We are going to get more epidemics as biodiversity declines, population grows and proximity to animals increases